semaglutide cv benefit Cardiovascular risk reduction with once-weekly in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline risk profile in the SUSTAIN 6 trial Semaglutide Improves Cardiovascular Outcomes in
Description
According to Professor Jeon, semaglutide has been shown to have a weight loss rate of 5 percent in 86 percent of patients and a weight loss rate of 20 percent or more in nearly 30 percent
doi: 10.1038/sj.ijo.0801251
[DOI] [PubMed] [Google Scholar] 39.Klein A, Stern N, Osher E, Kliper E, Kesler A
Novo Nordisk reports up to 13.8% weight loss in people with obesity receiving semaglutide in phase 2 trial
